Cargando…
Adjuvant chemotherapy may improve long-term outcomes in stage IB non-small cell lung cancer patients with previous malignancies: A propensity score-matched analysis
BACKGROUND: Routine administration of adjuvant chemotherapy for stage IB non-small cell lung cancer (NSCLC) remains controversial. To our knowledge, no available studies have assessed the outcomes of chemotherapy in patients with stage IB NSCLC who had prior malignancies. METHODS: Patients with path...
Autores principales: | Zhou, Ke, Zhao, Yaqin, Liang, Linchuan, Cao, Jie, Lin, Huahang, Peng, Zhiyu, Mei, Jiandong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472252/ https://www.ncbi.nlm.nih.gov/pubmed/36119504 http://dx.doi.org/10.3389/fonc.2022.938195 |
Ejemplares similares
-
Surgery and chemotherapy cannot improve the survival of patients with early-stage mucosa-associated lymphoid tissue derived primary pulmonary lymphoma
por: Lin, Huahang, et al.
Publicado: (2022) -
Prognostic role of the platelet to lymphocyte ratio (PLR) in the clinical outcomes of patients with advanced lung cancer receiving immunotherapy: A systematic review and meta-analysis
por: Zhou, Ke, et al.
Publicado: (2022) -
Impact of Adjuvant Chemotherapy on Variant Histology of Upper Tract Urothelial Carcinoma: A Propensity Score-Matched Cohort Analysis
por: Lo, Chi-Wen, et al.
Publicado: (2022) -
Neoadjuvant Chemotherapy Followed by Surgery Versus Abdominal Radical Hysterectomy Alone for Oncological Outcomes of Stage IB3 Cervical Cancer—A Propensity Score Matching Analysis
por: Li, Weili, et al.
Publicado: (2021) -
Synergy of Losartan and chemotherapy for patients with cholangiocarcinoma: A propensity score-matched analysis
por: Li, Qing, et al.
Publicado: (2022)